Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Giordano Novak Rossi"'
Autor:
José Diogo R. Souza, Julia Cozar Pacheco, Giordano Novak Rossi, Bruno O. de-Paulo, Antonio W. Zuardi, Francisco S. Guimarães, Jaime E. C. Hallak, José Alexandre Crippa, Rafael G. Dos Santos
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2598 (2022)
(1) Background: With the massive demand for the use and commercialization of medicinal cannabidiol (CBD) products, new randomized clinical trials (RCTs) are being published worldwide, with a constant need for safety and efficacy evaluation. (2) Metho
Externí odkaz:
https://doaj.org/article/ef11758683e14a40b61b14b1ae03c6e7
Autor:
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, Serdar M. Dursun, José Carlos Bouso Saiz, Jaime E. C. Hallak, Rafael G. dos Santos
Publikováno v:
Biomolecules, Vol 12, Iss 11, p 1618 (2022)
Ayahuasca is a psychoactive brew traditionally used in indigenous and religious rituals and ceremonies in South America for its therapeutic, psychedelic, and entheogenic effects. It is usually prepared by lengthy boiling of the leaves of the bush Psy
Externí odkaz:
https://doaj.org/article/79d55a4a671e4bc29a7188ab4dfee46f
Autor:
Juliana Mendes Rocha, Giordano Novak Rossi, Flávia L. Osório, José Carlos Bouso Saiz, Gabriela De Oliveira Silveira, Mauricio Yonamine, Eduardo José Crevelin, Maria Eugênia Queiroz, Jaime E. Cecílio Hallak, Rafael Guimarães Dos Santos
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Rationale: Previous studies with the serotonergic hallucinogens LSD and psilocybin showed that these drugs induced changes in personality traits, such as increases in Openness. However, results are inconsistent, and the effects of ayahuasca on person
Externí odkaz:
https://doaj.org/article/1759a601599c4d8396160b8d177157e6
Autor:
Gabriela de Oliveira Silveira, Rafael Guimarães dos Santos, Felipe Rebello Lourenço, Giordano Novak Rossi, Jaime E. C. Hallak, Mauricio Yonamine
Publikováno v:
Molecules, Vol 25, Iss 9, p 2072 (2020)
Ayahuasca tea is a hallucinogenic beverage used for religious purposes in Brazil and many other countries that has therapeutic potential in the treatment of some mental health disorders. In the context of psychedelic research, quantification of the t
Externí odkaz:
https://doaj.org/article/fe1675d41780410a997ce761abbc9283
Autor:
Guilherme Henrique de Morais Santos, Lucas Silva Rodrigues, Juliana Mendes Rocha, Giordano Novak Rossi, Genís Ona, José Carlos Bouso, Jaime Eduardo Cecilio Hallak, Rafael Guimarães dos Santos
Publikováno v:
Psychoactives. 2:76-91
Background: Ayahuasca is a serotoninergic hallucinogen that plays a central role in the Amazonian traditional medicine. Its psychoactive effects are associated with the presence of N,N-dimethyltryptamine (DMT), and monoamine oxidase inhibitors (MAO-A
Autor:
Rafael G, Dos Santos, Giordano Novak, Rossi, Jaime E C, Hallak, Dost, Öngür, Serdar M, Dursun
Publikováno v:
Current Neuropharmacology. 21:10-12
Autor:
Giordano Novak Rossi, Isabella Caroline da Silva Dias, Glen Baker, José Carlos Bouso Saiz, Serdar M. Dursun, Jaime E. C. Hallak, Rafael G. Dos Santos
Publikováno v:
Expert Opinion on Drug Safety. 21:789-801
Ayahuasca is a psychedelic brew originally used by Amazonian indigenous groups and in religious rituals. Pre-clinical and observational studies have demonstrated its possible potential as an antidepressant, and open- and placebo-controlled clinical t
Autor:
Juliana Mendes Rocha, Giordano Novak Rossi, Flávia L. Osório, Jaime E. Cecílio Hallak, Rafael Guimarães dos Santos
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e178f7310b6e98427def4ccc27a27245
Autor:
Giordano Novak, Rossi, Jaime E C, Hallak, Glen, Baker, Serdar M, Dursun, Rafael G, Dos Santos
Publikováno v:
European archives of psychiatry and clinical neuroscience.
Although results are still preliminary, ketamine and classical hallucinogens have shown promise in recent years as novel, fast-acting antidepressants, especially for the treatment of unipolar treatment-resistant depression (TRD). Depression also seem